Prelude Capital Management’s Endologix Inc ELGX Stock Holding History

Prelude Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30	Closed	-$2K	–	2203
2018 Q2	$2K	Sell	30 -15	-33%	-$761	﹤0.01%	1606
2018 Q1	$2K	Buy	+45	New	+$1.93K	﹤0.01%	1456
2017 Q4	–	Sell	-21	Closed	-$1K	–	1903
2017 Q3	$1K	Buy	+21	New	+$957	﹤0.01%	1576
2016 Q4	–	Sell	-1,620	Closed	-$207K	–	1918
2016 Q3	$207K	Buy	1,620 +24	+2%	+$3.07K	0.02%	555
2016 Q2	$199K	Buy	+1,596	New	+$183K	0.03%	497
2015 Q2	–	Sell	-1,933	Closed	-$330K	–	2222
2015 Q1	$330K	Buy	+1,933	New	+$293K	0.05%	472
2014 Q1	–	Sell	-210	Closed	-$37K	–	2211
2013 Q4	$37K	Buy	+210	New	+$36.1K	0.01%	1159

Other funds holding ELGX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Prelude Capital Management's ELGX Position: Q3 2018 in Review

Prelude Capital Management sold out of Endologix Inc (ELGX) in Q3 2018, closing a stake of 30 shares — an estimated $2K sold.

Prelude Capital Management first reported a position in ELGX in Q4 2013 and held it in 7 quarters. The position peaked at $330K in Q1 2015. 100 funds tracked by Wall St. Rank hold ELGX as of Q3 2018.

Prelude Capital Management reported no remaining Endologix Inc position as of Q3 2018 after selling out during the quarter.
Prelude Capital Management sold 30 Endologix Inc shares in Q3 2018, an estimated $2K.
Prelude Capital Management first reported a position in Endologix Inc in Q4 2013 and held it in 7 quarters.
Prelude Capital Management's Endologix Inc position peaked at $330K in Q1 2015.
100 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2018.

Based on Prelude Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.